Skip to main content
Premium Trial:

Request an Annual Quote

GC Biotech to Distribute CryoXtract Products in Benelux, Germany

NEW YORK (GenomeWeb News) – CryoXtract Instruments said this week that it has entered into an exclusive distribution deal with GC Biotech for the distribution of CryoXtract's automation solutions for preserving and optimizing frozen biological samples in the Benelux countries and Germany.

The deal is the first international partnership by CryoXtract since it named John McCarthy its CEO last month, it said, adding that the Benelux region and Germany is one of "the most important and progressive European markets for human genetics research and development," with a need for "sophisticated biobanking requirements."

The agreement provides CryoXtract "with a broad and experienced foundation of marketing, engineering support, and logistics services throughout this important European market," McCarthy said in a statement. "GC biotech represents the first of what we expect will be a network of strong international partners that can help accelerate introduction and adoption of our high-value products among the industry's thought leaders."

Financial and other terms of the deal were not disclosed.

CryoXtract, based in Woburn, Mass., develops automation solutions for retrieving multiple frozen samples from a single frozen biosample "without exposing the source sample to the deleterious biological impact from freeze/thaw cycling," it said. The firm has developed a technology platform for aliquotting biosamples while preserving the minus-80 degree Celsius environment.

GC biotech is based Alphen aan den Rijn, The Netherlands and distributes specialized life science products.